Melanization is a property that is shared among several human pathogenic fungi, whereas encapsulation is a property unique to Cryptococcus neoformans. Focusing on C. neoformans, the current knowledge of the structure and synthesis of the melanin and polysaccharide capsule is discussed. The importance of such basic biological information is underscored by the involvement of each to the pathogenic ability of the fungus and their potential as drug targets, yet areas where critical data remain elusive are clearly visible. Finally, in recognition of the fact that C. neoformans is a free-living organism, we conclude by examining the possible biological importance of each of these traits for environmental survival of the fungus.
Cryptococcus neoformans is the causative agent of cryptococcosis, a life-threatening disease that often involves the central-nervous system. Cryptococcosis is primarily a disease of individuals with impaired immune systems, although it sometimes affects individuals who are otherwise apparently healthy. In patients with advanced HIV infection, the prevalence of cryptococcosis ranges from 6-8% and the lifetime risk for cryptococcal disease in recipients of renal transplants approaches 10% (reviewed in [1] ). Despite the relative rarity of symptomatic C. neoformans infection in normal individuals, there is serological evidence that human infection is common and that it occurs in early childhood [2] . C. neoformans infections are acquired by inhalation of infectious particles [1] . It is generally believed that in the majority of normal individuals, infection is asymptomatic and contained in the lung by a granulomatous response [1] . In some individuals the initial infection can result in the persistence of C. neoformans in the lung in subpleural granulomas, which have the potential for later reactivation [3, 4] .
C. neoformans has several well-de ned virulence factors that include a polysaccharide capsule and the ability to make melanin-like pigments when cultured in media with de ned phenolic substrates [5] [6] [7] . Here we review the state of knowledge on melanin and capsule synthesis.
Pigment synthesis by Cryptococcus neoformans
The ability of C. neoformans to make dark pigments in certain agar was discovered by Staib in the 1960s and has been used to identify this fungus (reviewed in [8] ). Unlike other fungi that can make pigments endogenously, C. neoformans pigment production requires the presence of exogenous substrates such as ortho-and para-diphenols and catecholamines including dopamine, epinephrine, norepinephrine and 3,4-dihydroxyphenyl alanine (DOPA) [9] [10] [11] . The color and the solubility of the pigment are dependent on the substrate used. The most common substrates used to study melanization in the laboratory are the catecholamines. This results in the production of a cell-associated black pigment. This pigment was long thought to be a melanin but de nitive evidence that the pigment was a melanin-like compound was provided in 1995 by electron-spin-resonance studies [12] . Pigment formation is catalysed by a laccase enzyme, which is believed to convert substrate to melanin through a Mason-Raper scheme [13, 14] . Melanins remain enigmatic compounds and are not de ned chemically [15] . Isolation of melanins can be dif cult because these pigments are often strongly associated with other cellular components. Current techniques for the isolation of melanins use strong acids that could potentially affect its native structure. Given uncertainty as to the de nition and composition of melanin, it is probably more appropriate to refer to the pigments as 'melanin-like', and such terminology will be used here. The phenomenon of melanization in C. neoformans and its role in virulence has been the subject of at least four comprehensive reviews in recent years [13, [16] [17] [18] . Furthermore, melanization in phytopathogenic fungi has been thoroughly reviewed [19] . Hence, we will focus primarily on new developments in this eld with emphasis on areas that require further research and/or are controversial.
The melanin-like pigment in Cryptococcus neoformans is cell-wall associated
Growth of C. neoformans in substrates such as L-DOPA results in the production of a black pigment that is cell associated. The time of melanization is variable and depends on substrate concentration and factors that can affect laccase activity such as glucose and temperature [20] . Comparison of melanized and non-melanized cells by electron microscopy revealed that the cell walls of melanized cells were more electron dense [12] , which is consistent with deposition of melanin-like pigments in the cell wall. Melanization of C. neoformans also results in an increase in cell-wall thickness [21] . Unequivocal evidence for localization of melanin to the cell wall comes from the observation that digestion of melanized cells with cell wall-degrading enzymes, denaturants and concentrated HCl results in a black residue that is composed of melanin 'ghosts' with the shape and dimensions of the parent cells [12, 22] . The location of the melanin-like pigment in the cell wall is consistent with the nding that laccase is a cell wall-associated enzyme [23] . The association of melanin with the cell wall is important for its putative role in virulence because it places this polymer in a position to interact with external substances such as microbicidal products of phagocytic cells. Various functions have been described for C. neoformans L-DOPA melanin ( Table 1 ).
The structure of Cryptococcus neoformans melanin-like pigment
Structural studies of melanins are exceedingly dif cult because they are insoluble in most solvents, and their amorphous and heterogeneous nature precludes X-ray crystallographic analysis. To date no structure for a naturally occurring melanin has been solved. The problem may be beyond current technology considering that melanins formed in the environment or during infection may be the result of polymerization of various substrates resulting in an extremely heterogenous structure [13] . The C. neoformans-derived black pigment produced in vitro by growth in media with L-DOPA has been analysed by electron-spin-resonance spectroscopy [12] and elemental analysis [22, 24] . The electron-spinresonance spectroscopy revealed that the pigment was a stable, free radical with spectroscopic features that de ned it as a melanin [12] . Elemental quantitative analysis of C. neoformans melanin 'ghosts' synthesized after growth in L-DOPA shows a C:N:O ratio of 16:2:5, which is signi cantly different from the ratio of 9:1:2 found in synthetic DOPA-melanin [24] . This difference in elemental composition is unlikely to result from the isolation process itself, as synthetic DOPA-melanin showed no difference in C:N:O ratio when processed through the same extraction procedure [24] . Instead, it is possible that melanin ghosts contain other substances incorporated into the melanin polymer by the polymerization process, which could alter the C:N:O ratio from the one that would have resulted from the polymerization of L-DOPA alone to form a pure DOPA-melanin [24] . Alternatively, it is conceivable that there are biochemical differences in the polymerization reaction carried out by this fungus that result in a polymer with a different elemental composition.
Synthesis of melanin-like pigments and virulence in Cryptococcus neoformans
The ability of C. neoformans to produce melanin-like pigments in vivo was associated with virulence by classical genetic studies in the 1980s [25, 26] . In the 1990s the contribution of laccase activity to virulence was rigorously established by gene disruption and comple- mentation studies [27] . However, there is some controversy as to whether the association between the capacity of the laccase to produce melanin-like pigments in vitro and virulence was due to production of melaninlike pigments in vivo or to the action of the laccase independently of the production of polymerized melanin [18, 28] .
In vitro studies comparing the susceptibility of C. neoformans to oxygen-and nitrogen-related oxidants revealed that melanized cells were signi cantly less vulnerable to the microbicidal effects of these reactive species than non-melanized cells [12, [29] [30] [31] [32] [33] . Electronspin-resonance spectroscopy studies have provided evidence for direct electron transfer from oxygen-and nitrogen-related oxidants in solution to cell wall-associated melanin, thus, validating the existence of a mechanism by which melanin can provide a protective role by reacting with these radicals and preventing damage to sensitive cellular structures [12] . Melanin can also provide protection against microbicidal peptides such as defensins and protegrins [34] , and can interfere with ingestion by phagocytic cells [12] . Furthermore, animal studies revealed that a high melanin-producing strain interfered with the development of a cellular immune response in murine pulmonary infection [35] . Although these data indicate that virulence was due to pigment synthesis, there was no evidence to support the production of melanin-like pigments during the course of infection. In 1999 two papers appeared that argued for and against the synthesis of polymerized melanin in the course of infection. Nosanchuk et al. used melaninbinding peptides to show the presence of melanin-like pigments in cell walls of C. neoformans cells in murine tissues [36] . However, Liu et al. were unable to show the presence ot polymerized melanin using biochemical techniques in a different model of murine infection, despite detecting laccase oxidative products [28] . Although reconciliation of these two reports has not been achieved, the discrepancy may lie in differences in the experimental systems (see discussion on this point in [17] ). Nevertheless, data accumulated over the past two years provides compelling evidence that polymerized melanin is synthesized during infection (see below). Synthesis of polymerized melanin in vivo would indicate that the protection from microbicidal and peptides oxidants observed in vitro also applies in vivo.
Laccase has also been proposed to have a role in promoting C. neoformans virulence independently of its ability to generate polymerized melanin in the cell wall [37] . Laccase has iron oxidase activity that can convert Fe(II) to Fe(III), and it inhibits killing of C. neoformans in a cell-free system [37] . Given this, laccase could contribute to virulence by protecting C. neoformans in the phagosome by oxidizing iron to Fe(III) and inhibiting hydroxyl-radical formation [37] .
Hence, it is likely that laccase contributes to virulence in C. neoformans through at least two mechanisms: formation of melanin in vivo (see below) and interfering with macrophage killing by inhibiting hydroxyl-radical formation. The relative contribution on each of these functions to virulence is not known.
Polymerized melanin is synthesized in vivo during infection
Several studies provide compelling evidence that cryptococcal infection is accompanied by the formation of melanin-like pigments on the fungal cell wall. First, studies with melanin-binding peptides revealed the formation of melanin-like compounds in the cell walls of C. neoformans cells in tissue [36] . Second, melanin ghosts were isolated from infected mice but not from uninfected tissues or tissues infected with a laccasede cient C. neoformans strain [38] . Melanin 'ghosts' have also been isolated from human brain tissue infected with C. neoformans [39] . Third, murine infection elicits an antibody response to fungal melanin providing immunological evidence for the presence of melanin pigment in infected tissue [36] . Fourth, serial analysis of infected tissue with light microscopy shows that cell walls darken progressively, which is consistent with the synthesis of dark melanin pigments [21] . Fifth, serial analysis of C. neoformans revealed a progressive thickening of the cell wall in infected murine tissue over 28 days, which has been shown to accompany cell-wall melanization [21] . Sixth, administration of melaninbinding monoclonal antibodies (mAbs) prolongs survival of mice with lethal cryptococcal infection [40] . The ability of melanin-binding monoclonal antibodies to affect the course of infection implies that melanin is synthesized during infection. Seventh, administration of the melanization-inhibiting compound, glyphosate, to lethally infected mice was associated with prolongation of survival [41] . Growth of C. neoformans in media containing homogenates of murine tissues reveals the formation of melanin-like pigments, indicating that mammalian tissue contains suf cient substrates for laccase to support melanization [38] . The exact substrate used for the synthesis of melanin-like pigments in vivo is not known but catecholamines are likely candidates, as they are found in signi cant concentrations in tissue [38] .
Capsule composition and isolation
The polysaccharide capsule of C. neoformans is external to the cell wall and consist of three components: mannoprotein, galactoxylomannan (GalXM) and glucur-onoxylomannan (GXM). Together, these three molecules are believed to form an intertwining network of strands that extends from 0.5-1.0 m m from the cell wall to 10-80 m m depending on the environmental conditions, and are referred to collectively as the capsule [1, 42] . GXM is the predominant polysaccharide component of cryptococcal capsule, accounting for almost 90% of the capsular material [43] .
Much of what we know and infer about the capsular structure is derived from studies of soluble capsular polysaccharides that are shed into the extracellular milieu of growing C. neoformans cultures. The availability of these polysaccharide in gram quantities has permitted the isolation and analysis of the individual components. GXM consists of glucuronic acid, xylose and mannose. It is routinely puri ed by precipitation with the ionic detergent hexadecyltrimethylammonium bromide (CTAB) [44, 45] , which interacts with the negatively charged glucuronic acid moiety. The neutral charge of GalXM and mannoprotein prevent their contamination of the GXM preparation by this method.
GalXM is composed of galactose, xylose and mannose, and mannoprotein contains mannose as the predominant sugar but it also contains some galactose and xylose. The two can be separated from each other by concanavalin A (ConA)-sepharose chromatography [46] . The terminal mannose-binding property of ConA allows retention of mannoprotein on a ConA-sepharose column, whereas GalXM passes in the ow-through [47] . Mannoprotein can be eluted from the column with methyl-a -Dmannopyranoside [46] .
Serotypes of Cryptococcus neoformans
Serological studies revealed that the C. neoformans capsule was antigenically diverse and consequently provided the rst evidence for structural diversity among strains. Rabbit antisera, raised against formalin-killed cryptococcal cells, binds to the capsule of C. neoformans and causes the cells to agglutinate. These sera have been used to de ne four serotypes of C. neoformans (A, B, C, D) [48, 49] . A fth serotype AD has been designated as such based on reactivity with serotype A-speci c and serotype D-speci c antisera. At the molecular level, some serotype AD strains contain diploid or aneuploid genomes and, therefore, it has been suggested that this serotype is the result of a genetic cross between haploid serotypes A and D [50, 51] . Alternative serotyping methods, using a panel of sera made against eight putative antigens or selected monoclonal antibodies directed against GXM, exist [52] [53] [54] . Currently, however, the agglutination assay remains the standard method for typing new strains and clinical isolates.
Studies exploring the genetic, biochemical, morphological and epidemiological differences between the different serotypes have de ned the close similarities of serotype A to D and serotype B to C [1] . As a result, the taxonomic description of C. neoformans was altered to include the use of variety nomenclature. Serotype A and D strains are C. neoformans var. neoformans, and serotype B and C strains are C. neoformans var. gatti. Examination of clinical, molecular and biological traits of serotype A and D has led to the proposal that serotype A strains are signi cantly different from serotype D strains, and should be re-named C. neoformans var grubii [55] . This new classi cation is still being assessed and the correct designation for serotype AD strains not resolved [56] [57] [58] .
Physical properties of the capsule
The capsule of C. neoformans is a negatively charged, hydrophilic extracellular structure. The hydrophilic nature of the capsule was shown by hydrophobicchromatography conditions [59] . The strong hydrophilicity of the capsule contrasts with the hydrophobic properties of the cell wall and plasma membrane. Although carbohydrates are naturally hydrophilic, a signi cant portion of the hydrophilicity of the capsule can be attributed speci cally to the glucuronic acid component of GXM [59] . Glucuronic acid is a negatively charged sugar that is also the main determinate of the overall surface charge of the cell [60, 61] . Measurements of the surface charge indicate that encapsulated cells have approximately eightfold greater negative charge than acapsular cells [61] .
The size of the capsule can vary between strains and is altered by different environmental conditions. Thickness, volume or molecular mass measurements are taken to assess capsule size. The most common measurement of capsule size is the thickness of the capsule, that is the distance from the cell wall to the outer edge of the capsule. It can range from less than 1 m m to 80 m m [42, 62] . The volume of the capsular space can be determined by calculating the spherical volume of the whole cell including the capsule, and subtracting the spherical volume of the cell without the capsule. Alternatively, the total volume of a population of cells can be determined by using the packed-cell volume [63] [64] [65] . Molecular mass determination has only been performed on the isolated polysaccharide components. The molecular weight of isolated GXM is approximately 1 £ 10 6 daltons (Da) as determined by gel-ltration chromatography [66] . GalXM, on the other hand, is much smaller with a reported molecular mass of approximately 275 000 Da § 24 000 Da [43] . This gure, however, may have some degree of inaccuracy as the presence of amino acids in the GalXM preparation probably re ects a small amount of contamination by mannoprotein, as it was later discovered to co-elute under the speci ed conditions [43, 67] .
The physical state of the polysaccharide is altered by the concentration of sodium chloride in the surrounding medium. In the presence of 1 M NaCl (a hypertonic concentration) the capsule contracts, leading to a decrease in its thickness and packed-cell volume [65] . This effect was not observed with hypertonic concentrations of glucose or glycerol but the effects of other salts or sugars have yet to be evaluated. These observations indicate that the capsule can undergo physical changes depending on the solution although the mechanism for this process is not understood.
Changes in capsular morphology
C. neoformans colonies have a smooth or mucoid morphology on standard growth agar. However, notable morphological differences have been described in the literature. The capsule is the most external structure on the fungal cell and is, therefore, probably responsible for most of the morphological attributes of the colony. Acapsular or hypocapsular strains tend to produce colonies with a dry morphology, as was observed for a clinical isolate that lost its ability to synthesize a capsule [68, 69] . Capsular phenotypes can easily be determined by mixing the cells with India ink, and inspecting them microscopically. More extreme morphological colony changes were observed by Goldman et al. on encapsulated strains [70] . At de ned frequencies, strains that normally give rise to smooth colonies also gave rise to wrinkled or serrated colonies, indicating that C. neoformans can undergo phenotypic switching. Another phenotype, pseudohyphal, was later described [71] . Analysis of the GXM by 1 H-NMR suggested that structural differences in the GXM were responsible for the observed phenotypic differences [71] . Thus, dramatic changes in the quantity or structure of the capsular material can lead to observable morphological changes.
Structure of GXM
The approximate 1 £ 10 6 Da GXM polysaccharide is composed of repeat units that consist of an a (1,3)mannopyranan trimer that is monosubstituted with b (1,2)-glucopyranosyl-uronic acid and b (1,2)-xylopyranose [47, 66] . On some strains, the mannan backbone can also be substituted with b (1,4)-xylopyranose monosaccharides ( Fig. 1) . Based on the molecular weight of these repeats, there are approximately 750-1365 repeat units per molecule of GXM. GXM has not been shown to contain any branch structures, with the caveat that the methods used to study this molecule may not have detected rare linkages between polysaccharide chains. The GXM structure from strains comprising the different serotypes varies by the number of xylose substitutions in the repeat unit, the particular mannose residue within the trimer that is substituted with xylose, and the linkage (1,2 or 1,4) between the mannose and xylose sugars. However, not all strains within a given serotype contain identical GXM structures. Considerable structural heterogeneity in the GXM within a serotype have been documented [45, [72] [73] [74] . This structural heterogeneity has been utilized to develop a classi cation scheme ('chemotyping') for strains based on the presence of six different GXM repeat units [73] . This method relies on the fact that each mannose within a repeat unit present in the GXM molecule will resonate in a 1 H-NMR spectra at a unique chemical shift, depending on the nearby monosaccharide substitutions. Hence, the repeat units become structural reporter groups (SRG). By using SRGs to analyse GXM structure, it is now clear that a single strain of C. neoformans can have more than one repeat unit. What is still unknown is whether each SRG forms individual strands on the surface of the organism or if the repeat units from the different SRGs form chimeric strands.
The presence of multiple SRGs and the ability to undergo phenotypic switching raises interesting biological questions about the necessity of individual C. neoformans strains to retain any one speci c GXM structure. A key area to understand, in terms of human disease and immunotherapy, is the stability of GXM structure during periods of selective pressure. Although one study has indicated a degree of stability, at least with regards to a speci c polysaccharide structure required for recognition by a monoclonal antibody, variation has been observed in serial clinical isolates from patients experiencing recurrent cryptococcal meningitis, and a spontaneous GXM structural variant was isolated in vitro [75, 76] .
The mannan backbone of GXM is modi ed by Oacetylation. The O-acetyl groups are important for virulence of the organism, and for recognition by most antibodies directed against the polysaccharide [76, 77] . Early attempts to chemically de ne the modi ed sugar strongly suggested that in the serotype D polysaccharide, it was only the mannose residues that were acetylated [78] . This was showed almost a decade later with a serotype A strain using 13 C-NMR [79] . Although not all mannose residues were modi ed, those that were contained O-acetyl groups at the O-6 position. Furthermore, mannoses that were substituted at O-2 or O-4 by other monosaccharides were as likely to be O-acetylated as unsubstituted mannose sugars [79] .
Structure of GalXM
GalXM is a minor component of the capsule and continues to be synthesized by the acapsular strain Cap67 [80] . In terms of resolving the structure of GalXM, this particular trait of the Cap67 strain proved extremely useful as GalXM was isolated without any potential for GXM contamination of the preparation [67, 81] . The resulting structure shows the complexity of GalXM compared to GXM (Fig. 2) . The a (1,6)-galactan backbone can contain branch structures at every other galactose residue. These oligosaccharide branches are attached to the galactan backbone at the O-3 position and consist of b (1,3)-linked galactose, a (1,4)-linked mannose and a (1,3)-linked mannose. Each of these sugars in the oligosaccharide can in turn be substituted by b (1,2)-linked or b (1,3)-linked xylose. Four potential branch structures have been deduced, although the exact frequency with which any are used cannot presently be determined [81] . Interestingly, galactose is present in both the pyranose and furanose ring structures, and the data indicate that, like xylose and mannose, the galactofuranose structure is present at non-reducing terminal positions [81] . O-acetyl groups are present on GalXM; however, the precise residue(s) that is modi ed has not been determined [43] . The role of GalXM in capsule architecture or synthesis is not understood. Furthermore, the role of GalXM in virulence, if any, is unknown.
Synthesis of the capsule
Little is known about how C. neoformans synthesizes its immense capsule, and how all of the components are transported to the surface and assembled into the capsular structure. Several genes have been shown to be essential in capsule synthesis. CAP10, CAP59, CAP60 and CAP64 were isolated by genetic complementation of acapsular mutants [82] [83] [84] [85] . None of these genes show similarity to genes from other organisms, and their function in capsule synthesis is unknown. Thus, they potentially encode novel or highly divergent proteins that have evolved for speci c enzymatic or regulatory roles in capsular biosynthesis. Highly conserved genes that are essential in regulating capsule production are discussed below. Cellular localization studies have been carried out for two of the CAP proteins. The CAP10 protein localized to distinct areas of the cytoplasm, whereas the CAP60 protein localized to the nuclear membrane [84, 85] . The signi cance of their locations with regards to their function will become clear as more is understood about their role in the capsule biosynthetic process. The gene that encodes phosphomannose isomerase, MAN1, has been cloned as the enzyme is involved in the synthesis of GDP-mannose, a pathway that should be critical to capsule synthesis [86] . As expected, deletion of MAN1 leads to widespread cellular changes and affects GXM synthesis [86] . Discovery of other candidate genes important for the enzymatic synthesis of the capsule will be aided by the current efforts to sequence the cryptococcal genome. Several biochemical studies have identi ed enzymatic activities that should be important for the synthesis of GXM, which comprises almost 90% of the capsular material. Glucuronic acid and xylose can be synthesized by the cell from UDP-glucose. UDP-glucose dehydrogenase converts cytosolic glucose to UDP-glucuronic acid. This enzymatic activity was localized to the cytosol and the gene encoding UDP-glucose dehydrogenase is reportedly cloned [87, 88] . The UDP-glucuronic acid produced by this reaction conceivably can be assembled into a GXM molecule or catalysed to UDP-xylose by UDP-glucuronic acid decarboxylase. The NAD-dependent decarboxylase activity is greatest during early to mid-log growth, which would be consistent with the need for capsule synthesis on newly forming daughter cells [89] . NADH and UDP-xylose inhibit both enzymes.
Synthesizing the GXM polysaccharide repeat from the monosaccharides is expected to require a number of glycosyl transferases. The genes encoding for such transferases are presently unknown but the enzymatic activities of a few candidate transferases have been identi ed. Extension of the disaccharide a (1,3)-mannobiose by a single a (1,3)-linked mannose, using crude membrane preparations from C. neoformans, has led to the identi cation of an a (1,3)-mannosyltransferase [90] . The enzyme requires the presence of manganese, magnesium or cobalt for activity, with the maximal activity being manganese-dependent. Other mannosyltransferases with similar cation requirements have also been identi ed, but their enzymatic activities are speci c for the formation of a (1,2)-dimannosides, and they are not thought to be involved in GXM synthesis [90, 91] . Xylosyltransferase and glucuronyltransferase activities have been studied to determine the order of side-group addition on the mannan backbone [92] . This study suggests that modi cations occur by the sequential addition of acetyl groups, then glucuronic acid and lastly xylose.
The mechanism by which GXM synthesis is initiated remains a mystery. Peptide and lipid primers have been postulated, but conclusive ndings are lacking. Attempts to identify dolichyl phosphate-linked oligosaccharide intermediates of GXM have been unsuccessful, perhaps suggesting that a lipid primer is not used [90, 91] .
The unexpected observations that the GXM structure on daughter cells may be different from the mother cell may provide new insight into the regulation and biosynthesis of GXM [93, 94] . In these studies, budding cryptococcal mother cells retained their ability to bind two different monoclonal antibodies that speci cally recognize GXM. However, the capsule of a signi cant portion of the attached daughter cells were unable to be recognized by one of these antibodies, indicating that the epitope for this particular antibody may not have been synthesized yet.
Assembly and attachment of GXM
How the GXM polysaccharide is assembled and attached to the organism is an area where only a minute amount of data exists. An unresolved question is whether the full-length molecule is synthesized in a single continuous strand or if repeat units must be assembled. If the repeat units must be linked, does this assembly occur in transport vesicles, in the cell wall during translocation or on the surface of the cell? Does C. neoformans use a speci c translocation apparatus or a GXM-speci c polymerase, much as bacteria do in the assembly of their capsules [95] ? As data in this area increases, it will be interesting to see how similar the mechanism used by C. neoformans is to that used by bacteria for capsule attachment to the cell wall.
One of the more unusual features of GXM is the ability of puri ed GXM to attach to the surface of an acapsular cell, albeit not in suf cient quantity to generate a normal sized capsule [96] . Once attached, the puri ed GXM confers the same anti-phagocytic property that is normally associated with the de novo synthesized capsule on encapsulated cells [96] . Subsequent characterization of this phenomenon showed that saturable binding only occurred on acapsular cells, and attachment occurred by a slowly reversible mechanism [97, 98] . The ability of GXM to directly attach to the cells in a simple phosphate buffer would suggest that it attaches by a non-covalent means, although the presence of an enzymatic reaction occuring at the surface and leading to the formation of a covalent bond cannot be dismissed. A putative receptor for GXM remains to be discovered but data indicates it may be highly unusual, as GXM binding could only be prevented by speci c treatment of the GXM, not the cells, with proteinase XIV [97, 98] . The activity of this enzyme implies that there is a peptide associated with GXM but to date such evidence has not been established.
Attachment and assembly of polysaccharide on the surface of the cell is an on-going process as the cell grows and undergoes mitotic division. A model for synthesis of new capsular material has been proposed whereby new polysaccharide material is added to existing strands near the cell wall, and new polysaccharide strands intertwine into the existing capsule [93] . Further experimental validation of this model or generation of new models will undoubtedly occur as more is learned about this process.
Release of GXM into the extracellular milieu
Capsular polysaccharide material is released from the cell and can be identi ed in culture supernatants, the serum of infected hosts and in cytoplasmic vacuoles of infected macrophages. It remains to be determined if loss of the attached GXM is a direct consequence of the surrounding environmental conditions or a biochemical process regulated by the organism. Under standard broth culture condition in the laboratory, GXM release could theoretically be viewed as a normal outcome of polysaccharide that fails to attach, as a response to nutrient availability or as a physical shearing due to centripetal forces. Some of these possibilities may also exist in the in vivo setting. As a facultative, intracellular organism, C. neoformans may use different mechanisms for GXM release depending on whether it is inside or outside of a cell. The intracellular environment confronted by Cryptococcus can be replicated in vitro using cell-line-derived macrophages [99, 100] . Again, loss of GXM while the organism is in the phagolysosome could be a consequence of the intracellular milieu, such as a destabilizing pH or ion concentration, or a response by the yeast to its intracellular environment.
The mechanisms of GXM attachment and removal are probably intimately associated with each other. However, it is interesting that in contrast to the mild conditions used to study capsular attachment, experimental removal of the capsule from encapsulated organisms requires signi cantly more harsh conditions, such as hot HCl [101, 102] . These conditions may destroy the GXM structure so explorations of other conditions useful for more gentle disassociation may elucidate important characteristics of the non-covalent bond between GXM and the cell.
Environmental regulation of capsule synthesis
Capsule production is greatly affected by the surrounding environment. Carbon dioxide concentrations, temperature and pH have been shown to change the size of the capsule [63, 65, 69, 103] . Such conditions may be extremely relevant to cryptococcal pathogenicity, as the size of the capsule, a main virulence factor, is not only increased in vivo relative to in vitro conditions but also differs among infected organs within a host [42, 104] . Nutrient concentrations have also a clear effect on capsule size. High concentrations of glucose, sodium chloride, thiamine or iron (Fe(III)) decrease capsule size [65, 69, 103, 105] . Interestingly, deprivation of another nutrient nitrogen serves as a signal for the mating response in C. neoformans [106] . Deletion of the C. neoformans homologues of STE12-a global transcrip-tional activator in Sacchromyces that is targeted by the mating pheromone-responsive MAP-kinase signalling cascade-led to a reduction in capsule size in vivo, a decrease in the transcription of the CAP genes and a decrease in murine virulence [107] [108] [109] . Thus, nitrogen starvation can in uence capsule synthesis via the mating response. Furthermore, transcription of the laccase gene was also decreased, indicating a regulatory role of the STE12 homologue in melanin production [84, 107, 108] . It is important to note that these results were observable only in a serotype D strain, and the reduction in capsule size occurred only under in vivo conditions. A second signalling cascade that is cyclic-AMP-dependent is also known to be important for capsule production. This pathway, which uses the G-a protein Gpa1 and protein kinase A, is not involved in the mating pathway but is activated by the deprivation of iron [64, 110] . Other signalling pathways important for capsule synthesis and their corresponding stimulants may exist. Other mechanisms involved in maintaining or changing capsule size, such as the in uence of assembly or release processes, also need to be investigated.
Capsule as a virulence factor
The capsular polysaccharide of C. neoformans is inarguably a virulence factor for the organism, and it retains this capacity whether it is directly attached to the organism or not. Encapsulated yeasts are less easily phagocytosed and killed by the immune system then acapsular ones, thus enabling them to evade one aspect of the host defenses. Released capsular material also seems capable of thwarting the immune system. The effect of soluble GXM, in particular, is being actively studied. The expanding literature on immunoregulation by GXM is beyond the scope of this review, however two recent reviews synthesize the current knowledge on this topic [111, 112] .
Melanization and capsule synthesis as a target for drug development
The association of pigment synthesis with virulence combined with the evidence that melanin-like pigments are synthesized during infection indicates that compounds that interfere with melanization could be useful in the therapy of C. neoformans infection. Evidence for this concept is provided by the observation that glyphosate administration prolonged survival in mice [41] . Glyphosate interferes with melanin synthesis in C. neoformans and administration of this compound to lethally infected mice was associated with delayed formation of melanin 'ghosts' in tissue [41] . As melanization makes cells less susceptible to amphotericin B [113] , interference with melanization could enhance the ef cacy of existing antifungal drugs. Another strategy is to take advantage of the fact that melanin has a high af nity for many compounds, and to design drugs that bind melanin and are concentrated by melanized cells. In this regard, melanized cells are more susceptible to tri uoperazine and chloroquine than non-melanized cells [33] .
Monoclonal antibodies that recognize the capsule of C. neoformans have been put forth as potential reagents for immunotherapy. One such antibody 18B7 is currently in phase I clinical trials. However, beyond immunotherapy, the myriad of biochemical and cell biological processes that are undoubtedly a part of capsular biosynthesis should provide targets for chemotherapy. Speci c disruption of capsular synthesis would be unlikely to directly kill C. neoformans but acapsular strains are often avirulent and are more easily phagocytosed and killed by macrophages. Thus, such drugs should more readily permit clearing of the organisms by the immune system. The extent to which the capsule would act as a physical barrier to potentially active chemotherapeutics is unknown but inhibitors of capsular biosynthesis may lead to the discovery of potential synergistic combinations.
The role of melanization and the capsule in environmental survival
As C. neoformans is a free-living fungus that does not require parasitism in an animal host for survival, it is probable that the ability to synthesize melanin or produce a capsule was positively selected for by its environmental niche. C. neoformans cells in pigeon excreta is melanized [40, 114] , and it is likely that melanin is important for survival in the environment. In this regard, melanin has been shown to protect C. neoformans against ultraviolet light [115] , hot and cold temperatures [116] , the fungicidal effects of Ag ‡ [117] and cell wall-degrading enzymes such as those that may be produced by fungal predators [118] . The capsular polysaccharides may also have a role in environmental survival, as soil amoebae are less able to phagocytose capsular strains [119] , and melanin production by acapsular cells affords protection against amoebae [119] . Hence, it seems that both melanin and the capsule have the capacity to serve as a versatile armour-like barrier against a variety of environmental stresses.
